Physician profile
Leslie Deane
NPI 1700987153
$12,798.37
in general payments reported to CMS, 2019-2025
18 companies · $2,970 in 2025
The $2,970 reported for 2025 was more than what 86% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $723 · 2020: $74.60 · 2021: $273 · 2022: $3,273 · 2023: $2,656 · 2024: $2,829 · 2025: $2,970.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,050 · Long Term Medical Supply Or Device Loan: $2,442 · Food and Beverage: $941 · Entertainment: $22.44.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,050.00 |
| Long Term Medical Supply Or Device Loan | $2,442.24 |
| Food and Beverage | $940.66 |
| Entertainment | $22.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon INC. | $5,050.00 | 2023-2024 | |
| Intuitive Surgical, INC. | $4,200.51 | 2019-2023 | Da Vinci Surgical System |
| Integra Lifesciences Corporation | $2,442.24 | 2025 | Amnioexcel Plus |
| Corcept Therapeutics | $328.05 | 2024-2025 | Korlym |
| Axonics, INC. | $140.80 | 2022 | |
| Sumitomo Pharma America, INC. | $125.49 | 2024-2025 | Gemtesa, Orgovyx |
| Pfizer INC. | $99.62 | 2024-2025 | |
| Janssen Biotech, INC. | $88.81 | 2020-2024 | Erleada |
| Urogen Pharma, INC. | $60.60 | 2020 | |
| Ferring Pharmaceuticals INC. | $48.05 | 2024-2025 | Adstiladrin |
| Laborie Medical Technologies Corp. | $39.96 | 2025 | |
| Boston Scientific Corporation | $36.65 | 2025 | Spaceoar Vue System - 10ml |
| Convatec INC. | $35.91 | 2022 | |
| Provepharm INC. | $22.44 | 2024 | Bludigo |
| Olympus America INC. | $22.35 | 2023 | Itind System |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $19.81 | 2025 | Stratafix |
| Caris Mpi, INC. | $19.49 | 2025 | Mi Cancer Seek |
| Tempus Ai, INC | $17.59 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leslie Deane listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.